Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome

Lower urinary tract function is modulated by neural, vascular and urethral and bladder structural elements. The pathophysiological mechanisms of lower urinary tract symptoms (LUTS) encompass prostate enlargement, alterations in urethra histological structure bladder fibrosis and alterations in pelvi...

Full description

Bibliographic Details
Main Authors: Abdulmaged M. Traish, Vanessa Johansen
Format: Article
Language:English
Published: Korean Society for Sexual Medicine and Andrology 2018-09-01
Series:The World Journal of Men's Health
Subjects:
Online Access:https://www.wjmh.org/Synapse/Data/PDFData/2074WJMH/wjmh-36-199.pdf
id doaj-194aef0fb9e641f4914ebbd43ca767ec
record_format Article
spelling doaj-194aef0fb9e641f4914ebbd43ca767ec2020-11-24T22:18:04ZengKorean Society for Sexual Medicine and AndrologyThe World Journal of Men's Health2287-42082287-46902018-09-01363199222https://doi.org/10.5534/wjmh.180032Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic SyndromeAbdulmaged M. Traish0Vanessa Johansen1Department of Urology, Boston University School of Medicine, Boston, MA, USADepartment of Urology, Boston University School of Medicine, Boston, MA, USALower urinary tract function is modulated by neural, vascular and urethral and bladder structural elements. The pathophysiological mechanisms of lower urinary tract symptoms (LUTS) encompass prostate enlargement, alterations in urethra histological structure bladder fibrosis and alterations in pelvic neuronal and vascular networks, The complex pathophysiological relationship between testosterone (T) deficiency (TD) and the constellations LUTS, and metabolic dysfunction manifested in the metabolic syndrome (Met S) remains poorly understood. TD has emerged as one the potential targets by which Met S may contribute to the onset and development as well as worsening of LUTS. Because it has been recognized that treatment of men with Met S with T therapy ameliorates Met S components, it is postulated that T therapy may represent a therapeutic target in improving LUTS. Furthermore, the effect of TD on the prostate remains unclear, and often debatable. It is believed that T exclusively promotes prostate growth, however recent evidence has strongly contradicted this belief. The true relationship between benign prostatic hyperplasia, TD, and LUTS remains elusive and further research will be required to clarify the role of T in both benign prostatic hypertrophy (BPH) and LUTS as a whole. Although there is conflicting evidence about the benefits of T therapy in men with BPH and LUTS, the current body of literature supports the safety of using this therapy in men with enlarged prostate. As the population afflicted with obesity epidemic continues to age, the number of men suffering from Met S and LUTS together is expected to increase. https://www.wjmh.org/Synapse/Data/PDFData/2074WJMH/wjmh-36-199.pdfHypogonadismLower urinary tract symptomsMetabolic syndromeProstatic hyperplasiaTestosterone
collection DOAJ
language English
format Article
sources DOAJ
author Abdulmaged M. Traish
Vanessa Johansen
spellingShingle Abdulmaged M. Traish
Vanessa Johansen
Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome
The World Journal of Men's Health
Hypogonadism
Lower urinary tract symptoms
Metabolic syndrome
Prostatic hyperplasia
Testosterone
author_facet Abdulmaged M. Traish
Vanessa Johansen
author_sort Abdulmaged M. Traish
title Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome
title_short Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome
title_full Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome
title_fullStr Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome
title_full_unstemmed Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome
title_sort impact of testosterone deficiency and testosterone therapy on lower urinary tract symptoms in men with metabolic syndrome
publisher Korean Society for Sexual Medicine and Andrology
series The World Journal of Men's Health
issn 2287-4208
2287-4690
publishDate 2018-09-01
description Lower urinary tract function is modulated by neural, vascular and urethral and bladder structural elements. The pathophysiological mechanisms of lower urinary tract symptoms (LUTS) encompass prostate enlargement, alterations in urethra histological structure bladder fibrosis and alterations in pelvic neuronal and vascular networks, The complex pathophysiological relationship between testosterone (T) deficiency (TD) and the constellations LUTS, and metabolic dysfunction manifested in the metabolic syndrome (Met S) remains poorly understood. TD has emerged as one the potential targets by which Met S may contribute to the onset and development as well as worsening of LUTS. Because it has been recognized that treatment of men with Met S with T therapy ameliorates Met S components, it is postulated that T therapy may represent a therapeutic target in improving LUTS. Furthermore, the effect of TD on the prostate remains unclear, and often debatable. It is believed that T exclusively promotes prostate growth, however recent evidence has strongly contradicted this belief. The true relationship between benign prostatic hyperplasia, TD, and LUTS remains elusive and further research will be required to clarify the role of T in both benign prostatic hypertrophy (BPH) and LUTS as a whole. Although there is conflicting evidence about the benefits of T therapy in men with BPH and LUTS, the current body of literature supports the safety of using this therapy in men with enlarged prostate. As the population afflicted with obesity epidemic continues to age, the number of men suffering from Met S and LUTS together is expected to increase.
topic Hypogonadism
Lower urinary tract symptoms
Metabolic syndrome
Prostatic hyperplasia
Testosterone
url https://www.wjmh.org/Synapse/Data/PDFData/2074WJMH/wjmh-36-199.pdf
work_keys_str_mv AT abdulmagedmtraish impactoftestosteronedeficiencyandtestosteronetherapyonlowerurinarytractsymptomsinmenwithmetabolicsyndrome
AT vanessajohansen impactoftestosteronedeficiencyandtestosteronetherapyonlowerurinarytractsymptomsinmenwithmetabolicsyndrome
_version_ 1725783295113822208